Urban Wealth Management »

SPDR S&P Pharmaceuticals shares owned by Urban Wealth Management

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Urban Wealth Management from 13F filings

Historical chart of Urban Wealth Management investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Urban Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Urban Wealth Management

Quarter filed Position value Share count Share price at filing
2022-06-30 $2.0k 55 36.36

More positions owned by Urban Wealth Management

Alphabet Cap Stk Cl A (GOOGL)
Verizon Communications (VZ)
Ishares U S Etf Tr Commodity Curve (CCRV)
DaVita (DVA)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Us Infrastruc (IFRA)
Spdr Ser Tr Portfolio Ln Tsr (SPTL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
salesforce (CRM)
American Tower Reit (AMT)
Nushares Etf Tr Nuveen Esg Midvl (NUMV)
NVIDIA Corporation (NVDA)
Ishares Tr Core High Dv Etf (HDV)

View all positions for Urban Wealth Management

Top funds holding SPDR S&P Pharmaceuticals

Clal Insurance Enterprises Holdings
Bank of America Corporation
Kingsview Wealth Management
Bnp Paribas Arbitrage, Snc
First Citizens Bank & Trust
LPL Financial
Wells Fargo & Company
Envestnet Portfolio Solutions
Goldman Sachs Group
Susquehanna International
Citigroup
Wharton Business Group
UBS Group
MAI Wealth Advisors
Citadel Advisors

View all funds holding SPDR S&P Pharmaceuticals